Description

Hesseling et al modified the classification of Talbot et al for Bacille Calmette-Guerin (BCG)-induced disease in a pediatric patient. The authors are from Stellenbosch University in Tygerberg, South Africa, and the Academic Medical Centre in Amsterdam, The Netherlands.


 

Classification:

(1) local disease

(2) regional disease

(3) distant disease

(4) disseminated disease

(5) other BCG syndrome, probably immune-based

 

Local disease:

(1) limited to the site of vaccination

(2) may include an injection site abscess or scar ulceration

 

Regional disease:

(1) any regional lymph node ipsilateral to and beyond the vaccination site (axillary, cervical, etc.), with enlargement, suppuration and/or fistula

(2) any other regional lesion ipsilateral to vaccination site

 

Distant disease:

(1) involvement of 1 site NOT local or regional ipsilateral

(2) BCG isolated from 1 or more sites distant from the vaccination site (tracheal aspirate, gastric aspirate, CSF, urine, osteitis, skin)

(3) does not meet criteria for disseminated disease

(4) systemic symptoms (fever) are helpful for diagnosis but may be absent or nonspecific in an immunocompromised patient

 

Disseminated disease:

(1) 2 or more remote sites AND

(2) at least 1 blood or bone marrow culture positive

(3) systemic symptoms (fever) are helpful for diagnosis but may be absent or nonspecific in an immunocompromised patient

 

Other BCG syndromes include uveitis or keloid formation, with no organisms isolated on culture.

 

Need to exclude other disease, especially if immunocompromised.

 


To read more or access our algorithms and calculators, please log in or register.